Phase II study of pegylated liposomal doxorubicin (Caelyx) in advanced hepatocellular carcinoma (HHC).

被引：0
|
作者：
Ruff, P [1 ]
Moodley, SD [1 ]
Rapoport, BL [1 ]
Chasen, MR [1 ]
Jacobs, C [1 ]
Hacking, D [1 ]
Voroblof, DA [1 ]
机构：
[1] S African Caelyx Investigators Grp, Johannesburg, South Africa
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
306P
引用
收藏
页码：69 / 70
页数：2
相关论文
共 50 条
  • [1] A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma
    Halm, U
    Etzrodt, G
    Schiefke, I
    Schmidt, F
    Witzigmann, H
    Mössner, J
    Berr, F
    ANNALS OF ONCOLOGY, 2000, 11 (01) : 113 - 114
  • [2] A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma
    Ruey-Long Hong
    Yun-Long Tseng
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 433 - 438
  • [3] A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma
    Hong, RL
    Tseng, YL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (05) : 433 - 438
  • [4] Perspective phase I/II study of pegylated liposomal doxorubicin plus gemcitabine in advanced hepatocellular carcinoma
    Gianluca, D.
    Maria, L.
    Gaetana, L. G.
    Virginia, O.
    Rosa, T.
    Rosanna, D. S.
    Angelo, P.
    Gianfranco, F.
    ANNALS OF ONCOLOGY, 2006, 17 : XI53 - XI53
  • [5] A phase II study of Caelyx™ (liposomal doxorubicin) in the treatment of advanced gastric cancer
    Thomas, AL
    Jeffries, K
    Steward, WP
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2000, 83 : 45 - 45
  • [6] Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma
    M Schmidinger
    C Wenzel
    G J Locker
    F Muehlbacher
    R Steininger
    M Gnant
    R Crevenna
    A C Budinsky
    British Journal of Cancer, 2001, 85 : 1850 - 1852
  • [7] Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma
    Schmidinger, M
    Wenzel, C
    Locker, GJ
    Muehlbacher, F
    Steininger, R
    Gnant, M
    Crevenna, R
    Budinsky, AC
    Steger, GG
    BRITISH JOURNAL OF CANCER, 2001, 85 (12) : 1850 - 1852
  • [8] Pegylated Liposomal Doxorubicin and Gemcitabine in Patients With Advanced Hepatocellular Carcinoma Results of a Phase 2 Study
    Lombardi, Giuseppe
    Zustovich, Fable
    Farinati, Fabio
    Cillo, Umberto
    Vitale, Alessandro
    Zanus, Giacomo
    Donach, Martin
    Farina, Miriam
    Zovato, Stefania
    Pastorelli, Davide
    CANCER, 2011, 117 (01) : 125 - 133
  • [9] Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study
    J W Valle
    A Dangoor
    J Beech
    D J Sherlock
    S M Lee
    J H Scarffe
    R Swindell
    M Ranson
    British Journal of Cancer, 2005, 92 : 628 - 630
  • [10] Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study
    Valle, JW
    Dangoor, A
    Beech, J
    Sherlock, DJ
    Lee, SM
    Scarffe, JH
    Swindell, R
    Ranson, M
    BRITISH JOURNAL OF CANCER, 2005, 92 (04) : 628 - 630
12345